Related Experiment Video
Updated: Jul 12, 2025

Isolating Hair Follicle Stem Cells and Epidermal Keratinocytes from Dorsal Mouse Skin
Published on: April 29, 2016
Defining metabolic flexibility in hair follicle stem cell induced squamous cell carcinoma
Abstract:
Among the numerous changes associated with the transformation to cancer, cellular metabolism is one of the first discovered and most prominent[1, 2]. However, despite the knowledge that nearly every cancer is associated with the strong upregulation of various metabolic pathways, there has yet to be much clinical progress on the treatment of cancer by targeting a single metabolic enzyme directly[3-6]. We previously showed that inhibition of glycolysis through lactate dehydrogenase (LDHA) deletion in cancer cells of origin had no effect on the initiation or progression of cutaneous squamous cell carcinoma[7], suggesting that these cancers are metabolically flexible enough to produce the necessary metabolites required for sustained growth in the absence of glycolysis. Here we focused on glutaminolysis, another metabolic pathway frequently implicated as important for tumorigenesis in correlative studies. We genetically blocked glutaminolysis through glutaminase (GLS) deletion in cancer cells of origin, and found that this had little effect on tumorigenesis, similar to what we previously showed for blocking glycolysis. Tumors with genetic deletion of glutaminolysis instead upregulated lactate consumption and utilization for the TCA cycle, providing further evidence of metabolic flexibility. We also found that the metabolic flexibility observed upon inhibition of glycolysis or glutaminolysis is due to post-transcriptional changes in the levels of plasma membrane lactate and glutamine transporters. To define the limits of metabolic flexibility in cancer initiating hair follicle stem cells, we genetically blocked both glycolysis and glutaminolysis simultaneously and found that frank carcinoma was not compatible with abrogation of both of these carbon utilization pathways. These data point towards metabolic flexibility mediated by regulation of nutrient consumption, and suggest that treatment of cancer through metabolic manipulation will require multiple interventions on distinct pathways.
Insights
Cancer cells exhibit metabolic flexibility, adapting to blocked glycolysis or glutaminolysis by altering nutrient transporter levels. Targeting single metabolic pathways is insufficient; combined interventions are needed for effective cancer treatment.
Area of Science:
- Cancer Biology
- Cellular Metabolism
- Biochemistry
Background:
- Cellular metabolism undergoes significant changes during cancer development.
- Targeting single metabolic enzymes has shown limited clinical success in cancer treatment.
- Cancer cells display metabolic flexibility, adapting to the inhibition of key pathways like glycolysis.
Conclusions:
- Cancer cells possess significant metabolic flexibility, adapting to nutrient pathway inhibition.
- Metabolic flexibility is regulated by nutrient transporter expression, allowing cells to utilize alternative carbon sources.
- Effective cancer therapy targeting metabolism will require simultaneous inhibition of multiple distinct pathways.
Related Concept Videos
Multipotency and Niche of Bulge Stem Cell
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Renewal of Skin Epidermal Stem Cells
Accessory Structures of the Skin: Hair Growth and Types
Replicative Cell Senescence
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

